Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])

(2018) Xavier Carbonell-Estrany et al.   ACTA PAEDIATRICA

Bronchopulmonary Dysplasia: Can We Agree on a Definition?

(2018) Deepak Jain et al.   AMERICAN JOURNAL OF PERINATOLOGY

Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)

(2018) AdelS Alharbi et al.   Annals of Thoracic Medicine

Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence

(2018) Christian F Poets et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches

(2018) Sara A. Taleb et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Bronchopulmonary Dysplasia: Executive Summary of a Workshop

(2018) Rosemary D. Higgins et al.   JOURNAL OF PEDIATRICS

Bronchopulmonary Dysplasia: The Ongoing Search for One Definition to Rule Them All

(2018) Erik A. Jensen et al.   JOURNAL OF PEDIATRICS

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

(2018) Natalie I Mazur et al.   LANCET INFECTIOUS DISEASES

Persistent and progressive long-term lung disease in survivors of preterm birth

(2018) Rhea Urs et al.   Paediatric Respiratory Reviews

Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis

(2018) Michelle L Butt et al.   Paediatrics & Child Health

Risk Factors and Main Indications for Palivizumab Prophylaxis in a Second Season Population

(2018) Arne Simon et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Association of Age With Risk of Hospitalization for Respiratory Syncytial Virus in Preterm Infants With Chronic Lung Disease

(2018) Almut G. Winterstein et al.   JAMA Pediatrics

Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial

(2018) Nienke M Scheltema et al.   Lancet Respiratory Medicine

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value

(2018) Natalia Olchanski et al.   Open Forum Infectious Diseases

The definition of bronchopulmonary dysplasia: an evolving dilemma

(2018) John Ibrahim et al.   PEDIATRIC RESEARCH

Recent advances in the pathogenesis of BPD

(2018) Rory E. Morty   SEMINARS IN PERINATOLOGY

First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)

(2017) Daniel Y. Wang et al.   EUROPEAN JOURNAL OF PEDIATRICS

Early Mortality and Morbidity in Infants with Birth Weight of 500 Grams or Less in Japan

(2017) Hirosuke Inoue et al.   JOURNAL OF PEDIATRICS

Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia

(2017) Steven H. Abman et al.   JOURNAL OF PEDIATRICS

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

(2017) Ting Shi et al.   LANCET

Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

(2017) Dirk Bassler et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy

(2017) Paolo Manzoni et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Altered lung structure and function in mid-childhood survivors of very preterm birth

(2017) Shannon J Simpson et al.   THORAX

Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia

(2017) Petra Um-Bergström et al.   BMC Pulmonary Medicine

Lung function at term in extremely preterm-born infants: a regional prospective cohort study

(2017) Mariann Haavik Bentsen et al.   BMJ Open

Revisiting the Definition of Bronchopulmonary Dysplasia

(2017) Tetsuya Isayama et al.   JAMA Pediatrics

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series

(2017) Nienke M Scheltema et al.   Lancet Global Health

Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus

(2016) Delaney Hines et al.   ACTA PAEDIATRICA

A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life

(2016) Cristine E. Berry et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults

(2016) M. Pamela Griffin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children

(2016) Terho Heikkinen et al.   JOURNAL OF INFECTIOUS DISEASES

Risk factors associated with death in patients with severe respiratory syncytial virus infection

(2016) Yen-I Lee et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis

(2016) Renato T. Stein et al.   PEDIATRIC PULMONOLOGY

Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era

(2016) Lex W Doyle et al.   THORAX

A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice

(2016) Bosco A Paes et al.   Canadian Respiratory Journal

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012

(2016) Abigail Doucette et al.   PLoS One

Actualización de las recomendaciones de la Sociedad Española de Neonatología para la utilización del palivizumab como profilaxis de las infecciones graves por el virus respiratorio sincitial

(2015) J. Figueras Aloy et al.   ANALES DE PEDIATRIA

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

(2015) E. A. F. Simoes et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia

(2015) Young Mi Han et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia

(2015) Dirk Bassler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preventing hospitalizations for respiratory syncytial virus infection

(2015) Joan L Robinson et al.   Paediatrics & Child Health

New BPD predicts lung function at school age: Follow-up study and meta-analysis

(2015) Eveliina Ronkainen et al.   PEDIATRIC PULMONOLOGY

Neonatal Outcomes of Extremely Preterm Infants from Taiwan: Comparison with Canada, Japan, and the USA

(2015) Bai-Horng Su et al.   Pediatrics and Neonatology

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants—The SPRING Study

(2015) Xavier Carbonell-Estrany et al.   PLoS One

Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico

(2015) I Majer et al.   VALUE IN HEALTH

Lung function of preterm infants before and after viral infections

(2014) Simon B. Drysdale et al.   EUROPEAN JOURNAL OF PEDIATRICS

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation

(2014) D Wang et al.   HEALTH TECHNOLOGY ASSESSMENT

Palivizumab for immunoprophylaxis of respiratory syncitial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses

(2014) D Wang et al.   HEALTH TECHNOLOGY ASSESSMENT

Lung function in adult survivors of very low birth weight, with and without bronchopulmonary dysplasia

(2014) Anne-Marie Gibson et al.   PEDIATRIC PULMONOLOGY

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

(2014)   PEDIATRICS

Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort Study

(2014) Joanna Murray et al.   PLoS One

Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

(2013) Bosco Paes et al.   Clinical & Developmental Immunology

Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia

(2013) A. Gough et al.   EUROPEAN RESPIRATORY JOURNAL

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

(2013) H. C. Meissner et al.   PEDIATRICS

Effect of preterm birth on later FEV1: a systematic review and meta-analysis

(2013) Sarah J Kotecha et al.   THORAX

Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants

(2012) Alexandre Lapillonne et al.   BMC Pediatrics

Respiratory Function in Healthy Late Preterm Infants Delivered at 33-36 Weeks of Gestation

(2012) Cindy McEvoy et al.   JOURNAL OF PEDIATRICS

The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection

(2012) Shelagh M. Szabo et al.   Paediatric Respiratory Reviews

Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997

(2012) Douglas F. Hacking et al.   PEDIATRIC PULMONOLOGY

Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity

(2012) Silvia Ricart et al.   PEDIATRIC PULMONOLOGY

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

(2011) Bernhard Resch et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The new bronchopulmonary dysplasia

(2010) Alan H Jobe   CURRENT OPINION IN PEDIATRICS

Outcomes of Palivizumab Prophylaxis for Respiratory Syncytial Virus Infection in Preterm Children with Bronchopulmonary Dysplasia at a Single Hospital in Korea from 2005 to 2009

(2010) Seung Gu Chang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Childhood Course of Lung Function in Survivors of Bronchopulmonary Dysplasia

(2009) Marco Filippone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The ‘new’ bronchopulmonary dysplasia: challenges and commentary

(2009) T. Allen Merritt et al.   Seminars in Fetal & Neonatal Medicine

School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants

(2009) A Greenough et al.   THORAX

Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands

(2009) Mark Nuijten et al.   JOURNAL OF MEDICAL ECONOMICS

Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

(2008) K Thorburn   ARCHIVES OF DISEASE IN CHILDHOOD

Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria

(2008) Bernhard Resch et al.   CLINICAL THERAPEUTICS

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

(2008) M Frogel et al.   Journal of Perinatology